Treatment and evaluation of CLL: A complicated affair

Research output: Contribution to journalShort survey

1 Scopus citations

Abstract

In this issue, Eichhorst and colleagues show in a large randomized phase 3 clinical trial that combination therapy using fludarabine and cyclophosphamide is superior to fludarabine alone for younger previously untreated CLL patients. In addition, they found a reduced level of clinical responses when imaging was considered as part of restaging compared with responses defined by recommended NCI standards.

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume107
Issue number3
DOIs
StatePublished - Feb 1 2006

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Treatment and evaluation of CLL: A complicated affair'. Together they form a unique fingerprint.

  • Cite this